Torsten Schreiber

UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany.

Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI.

Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA.

Philippos Asset Management AG is an independent asset management firm headquartered in Zug, Switzerland. Founded in 2019, the firm provides investment advice to individual and institutional clients.

Zweite Gesellschaft zur Förderung kirchlich anerkannter is a healthcare services company based in Dusseldorf, Germany. Zweite Gesellschaft zur Förderung kirchlich anerkannter provides healthcare services. The German company was founded in 2014, and its CEOs are Michaela Steimel, Hans Mauel, Jochen Lüdicke.